ABSTRACT
The Novartis v. Union of India case epitomizes the delicate balance between patent protection and public health in the pharmaceutical sector. This landmark ruling in 2013 pivoted on the interpretation of Section 3(d) of the Indian Patent Act, underscoring the significance of enhanced drug efficac...Read More